Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium

https://doi.org/10.1097/PRS.0b013e318219c171

2.

Burns

PB

,

Rohrich

RJ

,

Chung

KC

.

The levels of evidence and their role in evidence-based medicine

.

Plast Reconstr Surg

.

2011

Jul

;

128

(

1

):

305

–

10

.

[PubMed]

0032-1052

https://doi.org/10.1542/peds.2012-3773

3.

Biro

FM

,

Greenspan

LC

,

Galvez

MP

,

Pinney

SM

,

Teitelbaum

S

,

Windham

GC

, et al.

Onset of breast development in a longitudinal cohort

.

Pediatrics

.

2013

Dec

;

132

(

6

):

1019

–

27

.

[PubMed]

0031-4005

https://doi.org/10.1016/j.jpag.2018.05.002

4.

Biro

FM

,

Pajak

A

,

Wolff

MS

,

Pinney

SM

,

Windham

GC

,

Galvez

MP

, et al.

Age of Menarche in a Longitudinal US Cohort

.

J Pediatr Adolesc Gynecol

.

2018

Aug

;

31

(

4

):

339

–

45

.

[PubMed]

1083-3188

https://doi.org/10.1542/peds.2008-2491

5.

Aksglaede

L

,

Sørensen

K

,

Petersen

JH

,

Skakkebaek

NE

,

Juul

A

.

Recent decline in age at breast development: the Copenhagen Puberty Study

.

Pediatrics

.

2009

May

;

123

(

5

):

e932

–

9

.

[PubMed]

0031-4005

https://doi.org/10.1159/000236085

6.

Teilmann

G

,

Petersen

JH

,

Gormsen

M

,

Damgaard

K

,

Skakkebaek

NE

,

Jensen

TK

.

Early puberty in internationally adopted girls: hormonal and clinical markers of puberty in 276 girls examined biannually over two years

.

Horm Res

.

2009

;

72

(

4

):

236

–

46

.

[PubMed]

0301-0163

https://doi.org/10.1016/S0022-3476(95)70255-5

7.

Neely

EK

,

Wilson

DM

,

Lee

PA

,

Stene

M

,

Hintz

RL

.

Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty

.

J Pediatr

.

1995

Jul

;

127

(

1

):

47

–

52

.

[PubMed]

0022-3476

https://doi.org/10.1542/peds.2008-1180

8.

Houk

CP

,

Kunselman

AR

,

Lee

PA

.

Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls

.

Pediatrics

.

2009

Jun

;

123

(

6

):

e1059

–

63

.

[PubMed]

0031-4005

https://doi.org/10.1111/j.1365-2265.2009.03735.x

9.

Martinez-Aguayo

A

,

Hernández

MI

,

Capurro

T

,

Peña

V

,

Avila

A

,

Salazar

T

, et al.

Leuprolide acetate gonadotrophin response patterns during female puberty

.

Clin Endocrinol (Oxf)

.

2010

Apr

;

72

(

4

):

489

–

95

.

[PubMed]

0300-0664

https://doi.org/10.1136/archdischild-2013-304414

10.

Harrington

J

,

Palmert

MR

,

Hamilton

J

.

Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty

.

Arch Dis Child

.

2014

Jan

;

99

(

1

):

15

–

20

.

[PubMed]

0003-9888

https://doi.org/10.1210/jc.2013-3292

11.

Bizzarri

C

,

Spadoni

GL

,

Bottaro

G

,

Montanari

G

,

Giannone

G

,

Cappa

M

, et al.

The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life

.

J Clin Endocrinol Metab

.

2014

Feb

;

99

(

2

):

433

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1530/EJE-17-0042

12.

Vestergaard

ET

,

Schjørring

ME

,

Kamperis

K

,

Petersen

KK

,

Rittig

S

,

Juul

A

, et al.

The follicle-stimulating hormone (FSH) and luteinizing hormone (LH) response to a gonadotropin-releasing hormone analogue test in healthy prepubertal girls aged 10 months to 6 years

.

Eur J Endocrinol

.

2017

Jun

;

176

(

6

):

747

–

53

.

[PubMed]

0804-4643

https://doi.org/10.1111/j.1365-2265.2010.03796.x

13.

Sathasivam

A

,

Garibaldi

L

,

Shapiro

S

,

Godbold

J

,

Rapaport

R

.

Leuprolide stimulation testing for the evaluation of early female sexual maturation

.

Clin Endocrinol (Oxf)

.

2010

Sep

;

73

(

3

):

375

–

81

.

[PubMed]

0300-0664

https://doi.org/10.1111/j.1365-2265.2012.04517.x

14.

Freire

AV

,

Escobar

ME

,

Gryngarten

MG

,

Arcari

AJ

,

Ballerini

MG

,

Bergadá

I

, et al.

High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls

.

Clin Endocrinol (Oxf)

.

2013

Mar

;

78

(

3

):

398

–

404

.

[PubMed]

0300-0664

https://doi.org/10.1530/eje.1.02151

15.

de Vries

L

,

Horev

G

,

Schwartz

M

,

Phillip

M

.

Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche

.

Eur J Endocrinol

.

2006

Jun

;

154

(

6

):

891

–

8

.

[PubMed]

0804-4643

https://doi.org/10.1016/j.jpeds.2011.02.032

16.

Sathasivam

A

,

Rosenberg

HK

,

Shapiro

S

,

Wang

H

,

Rapaport

R

.

Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test

.

J Pediatr

.

2011

Sep

;

159

(

3

):

490

–

5

.

[PubMed]

0022-3476

https://doi.org/10.1371/journal.pone.0029829

17.

Mogensen

SS

,

Aksglaede

L

,

Mouritsen

A

,

Sørensen

K

,

Main

KM

,

Gideon

P

, et al.

Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty

.

PLoS One

.

2012

;

7

(

1

):

e29829

.

[PubMed]

1932-6203

https://doi.org/10.6065/apem.2018.23.2.75

18.

Lee

J

,

Kim

J

,

Yang

A

,

Cho

SY

,

Jin

DK

.

Etiological trends in male central precocious puberty

.

Ann Pediatr Endocrinol Metab

.

2018

Jun

;

23

(

2

):

75

–

80

.

[PubMed]

2287-1012

https://doi.org/10.1515/jpem-2018-0052

19.

Cantas-Orsdemir

S

,

Garb

JL

,

Allen

HF

.

Prevalence of cranial MRI findings in girls with central precocious puberty: a systematic review and meta-analysis

.

J Pediatr Endocrinol Metab

.

2018

Jul

;

31

(

7

):

701

–

10

.

[PubMed]

0334-018X

https://doi.org/10.1186/s13633-016-0027-5

20.

Kaplowitz

PB

.

Do 6-8 year old girls with central precocious puberty need routine brain imaging?

Int J Pediatr Endocrinol

.

2016

;

2016

(

1

):

9

.

[PubMed]

1687-9848

https://doi.org/10.1016/S0022-3476(95)70254-7

21.

Neely

EK

,

Hintz

RL

,

Wilson

DM

,

Lee

PA

,

Gautier

T

,

Argente

J

, et al.

Normal ranges for immunochemiluminometric gonadotropin assays

.

J Pediatr

.

1995

Jul

;

127

(

1

):

40

–

6

.

[PubMed]

0022-3476

https://doi.org/10.1210/jc.2006-1569

22.

Resende

EA

,

Lara

BH

,

Reis

JD

,

Ferreira

BP

,

Pereira

GA

,

Borges

MF

.

Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children

.

J Clin Endocrinol Metab

.

2007

Apr

;

92

(

4

):

1424

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1530/EJE-11-0720

23.

Pasternak

Y

,

Friger

M

,

Loewenthal

N

,

Haim

A

,

Hershkovitz

E

.

The utility of basal serum LH in prediction of central precocious puberty in girls

.

Eur J Endocrinol

.

2012

Feb

;

166

(

2

):

295

–

9

.

[PubMed]

0804-4643

https://doi.org/10.1515/JPEM.2008.21.12.1113

24.

Houk

CP

,

Kunselman

AR

,

Lee

PA

.

The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate

.

J Pediatr Endocrinol Metab

.

2008

Dec

;

21

(

12

):

1113

–

8

.

[PubMed]

0334-018X

https://doi.org/10.1055/s-0034-1387790

25.

Carretto

F

,

Salinas-Vert

I

,

Granada-Yvern

ML

,

Murillo-Vallés

M

,

Gómez-Gómez

C

,

Puig-Domingo

M

, et al.

The usefulness of the leuprolide stimulation test as a diagnostic method of idiopathic central precocious puberty in girls

.

Horm Metab Res

.

2014

Dec

;

46

(

13

):

959

–

63

.

[PubMed]

0018-5043

https://doi.org/10.1159/000232164

26.

Poomthavorn

P

,

Khlairit

P

,

Mahachoklertwattana

P

.

Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty

.

Horm Res

.

2009

;

72

(

2

):

114

–

9

.

[PubMed]

0301-0163

https://doi.org/10.1159/000442523

27.

Freire

AV

,

Gryngarten

MG

,

Ballerini

MG

,

Arcari

AJ

,

Escobar

ME

,

Bergadá

I

, et al.

Assessment of Estradiol Response after Depot Triptorelin Administration in Girls with Central Precocious Puberty

.

Horm Res Paediatr

.

2016

;

85

(

1

):

58

–

64

.

[PubMed]

1663-2818

https://doi.org/10.1146/annurev.med.45.1.391

28.

Conn

PM

,

Crowley

WF

Jr.

Gonadotropin-releasing hormone and its analogs

.

Annu Rev Med

.

1994

;

45

:

391

–

405

.

[PubMed]

0066-4219

https://doi.org/10.1210/jcem-65-5-946

29.

Lahlou

N

,

Roger

M

,

Chaussain

JL

,

Feinstein

MC

,

Sultan

C

,

Toublanc

JE

, et al.

Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty

.

J Clin Endocrinol Metab

.

1987

Nov

;

65

(

5

):

946

–

53

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2009-2078

30.

Hirsch

HJ

,

Lahlou

N

,

Gillis

D

,

Strich

D

,

Rosenberg-Hagen

B

,

Chertin

B

, et al.

Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implant

.

J Clin Endocrinol Metab

.

2010

Jun

;

95

(

6

):

2841

–

4

.

[PubMed]

0021-972X

https://doi.org/10.1016/j.jpeds.2013.05.033

31.

Lewis

KA

,

Goldyn

AK

,

West

KW

,

Eugster

EA

.

A single histrelin implant is effective for 2 years for treatment of central precocious puberty

.

J Pediatr

.

2013

Oct

;

163

(

4

):

1214

–

6

.

[PubMed]

0022-3476

https://doi.org/10.1210/jc.2004-1863

32.

Tanaka

T

,

Niimi

H

,

Matsuo

N

,

Fujieda

K

,

Tachibana

K

,

Ohyama

K

, et al.

Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty

.

J Clin Endocrinol Metab

.

2005

Mar

;

90

(

3

):

1371

–

6

.

[PubMed]

0021-972X

https://doi.org/10.1530/eje.0.1320699

33.

Carel

JC

,

Lahlou

N

,

Guazzarotti

L

,

Joubert-Collin

M

,

Roger

M

,

Colle

M

, et al.;

French Leuprorelin Trial Group

.

Treatment of central precocious puberty with depot leuprorelin

.

Eur J Endocrinol

.

1995

Jun

;

132

(

6

):

699

–

704

.

[PubMed]

0804-4643

https://doi.org/10.1530/eje.1.02056

34.

Fuld

K

,

Chi

C

,

Neely

EK

. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty. JPediatr.

2011

;159(6):982-987.LoE-1

35.

Carel

JC

,

Blumberg

J

,

Seymour

C

,

Adamsbaum

C

,

Lahlou

N

;

Triptorelin 3-month CPP Study Group

.

Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty

.

Eur J Endocrinol

.

2006

Jan

;

154

(

1

):

119

–

24

.

[PubMed]

0804-4643

https://doi.org/10.1515/jpem-2015-0376

36.

Klein

K

,

Yang

J

,

Aisenberg

J

,

Wright

N

,

Kaplowitz

P

,

Lahlou

N

, et al.

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty

.

J Pediatr Endocrinol Metab

.

2016

Nov

;

29

(

11

):

1241

–

8

.

[PubMed]

0334-018X

https://doi.org/10.1177/0091270005281043

37.

Dineen

MK

,

Tierney

DS

,

Kuzma

P

,

Pentikis

HS

.

An evaluation of the pharmacokinetics and pharmacodynamics of the histrelin implant for the palliative treatment of prostate cancer

.

J Clin Pharmacol

.

2005

Nov

;

45

(

11

):

1245

–

9

.

[PubMed]

0091-2700

https://doi.org/10.1111/j.1365-2265.2009.03584.x

38.

Mericq

V

,

Lammoglia

JJ

,

Unanue

N

,

Villaroel

C

,

Hernández

MI

,

Avila

A

, et al.

Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results

.

Clin Endocrinol (Oxf)

.

2009

Nov

;

71

(

5

):

686

–

90

.

[PubMed]

0300-0664

https://doi.org/10.1186/1687-9856-2013-20

39.

Neely

EK

,

Silverman

LA

,

Geffner

ME

,

Danoff

TM

,

Gould

E

,

Thornton

PS

.

Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy

.

Int J Pediatr Endocrinol

.

2013

Dec

;

2013

(

1

):

20

.

[PubMed]

1687-9848

https://doi.org/10.1210/jc.2013-4471

40.

Lee

PA

,

Klein

K

,

Mauras

N

,

Lev-Vaisler

T

,

Bacher

P

.

36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty

.

J Clin Endocrinol Metab

.

2014

Sep

;

99

(

9

):

3153

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1542/peds.2009-3079

41.

Biro

FM

,

Galvez

MP

,

Greenspan

LC

,

Succop

PA

,

Vangeepuram

N

,

Pinney

SM

, et al.

Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls

.

Pediatrics

.

2010

Sep

;

126

(

3

):

e583

–

90

.

[PubMed]

0031-4005

https://doi.org/10.1542/peds.2008-2638

42.

Ma

HM

,

Du

ML

,

Luo

XP

,

Chen

SK

,

Liu

L

,

Chen

RM

, et al.;

Pubertal Study Group of the Society of Pediatric Endocrinology and Genetic Disease, Chinese Medical Association

.

Onset of breast and pubic hair development and menses in urban chinese girls

.

Pediatrics

.

2009

Aug

;

124

(

2

):

e269

–

77

.

[PubMed]

0031-4005

43.

Bereket

A

.

A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty

.

J Clin Res Pediatr Endocrinol

.

2017

Dec

;

9

Suppl 2

:

33

–

48

.

[PubMed]

1308-5735

https://doi.org/10.1001/jama.1986.03370190097031

44.

Comite

F

,

Cassorla

F

,

Barnes

KM

,

Hench

KD

,

Dwyer

A

,

Skerda

MC

, et al.

Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height

.

JAMA

.

1986

May

;

255

(

19

):

2613

–

6

.

[PubMed]

0098-7484

https://doi.org/10.1530/EJE-18-0473

45.

Franzini

IA

,

Yamamoto

FM

,

Bolfi

F

,

Antonini

SR

,

Nunes-Nogueira

VS

.

GnRH analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age: a systematic review and meta-analysis.

Eur J Endocrinol.

2018

;179(6):381-390.LoE-2

https://doi.org/10.1016/S0022-3476(95)70221-0

46.

Bar

A

,

Linder

B

,

Sobel

EH

,

Saenger

P

,

DiMartino-Nardi

J

.

Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height

.

J Pediatr

.

1995

Jun

;

126

(

6

):

955

–

8

.

[PubMed]

0022-3476

https://doi.org/10.1515/jpem.2011.005

47.

Jaruratanasirikul

S

,

Thongkum

K

,

Krisaneepaiboon

S

,

Sriplung

H

.

Girls with early puberty attain a near-final height similar to their target height

.

J Pediatr Endocrinol Metab

.

2011

;

24

(

5-6

):

339

–

45

.

[PubMed]

0334-018X

https://doi.org/10.12659/MSM.881794

48.

Allali

S

,

Lemaire

P

,

Couto-Silva

AC

,

Prété

G

,

Trivin

C

,

Brauner

R

.

Predicting the adult height of girls with central precocious puberty

.

Med Sci Monit

.

2011

Jun

;

17

(

6

):

PH41

–

8

.

[PubMed]

1234-1010

https://doi.org/10.1159/000479688

49.

Schoelwer

MJ

,

Donahue

KL

,

Didrick

P

,

Eugster

EA

.

One-Year Follow-Up of Girls with Precocious Puberty and Their Mothers: Do Psychological Assessments Change over Time or with Treatment?

Horm Res Paediatr

.

2017

;

88

(

5

):

347

–

53

.

[PubMed]

1663-2818

https://doi.org/10.3389/fpsyg.2016.01053

50.

Wojniusz

S

,

Callens

N

,

Sütterlin

S

,

Andersson

S

,

De Schepper

J

,

Gies

I

, et al.

Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty

.

Front Psychol

.

2016

Jul

;

7

:

1053

.

[PubMed]

1664-1078

https://doi.org/10.1016/j.jpeds.2005.10.020

51.

Biro

FM

,

Huang

B

,

Crawford

PB

,

Lucky

AW

,

Striegel-Moore

R

,

Barton

BA

, et al.

Pubertal correlates in black and white girls

.

J Pediatr

.

2006

Feb

;

148

(

2

):

234

–

40

.

[PubMed]

0022-3476

https://doi.org/10.1515/jpem-2013-0286

52.

Cabrera

SM

,

Bright

GM

,

Frane

JW

,

Blethen

SL

,

Lee

PA

.

Age of thelarche and menarche in contemporary US females: a cross-sectional analysis

.

J Pediatr Endocrinol Metab

.

2014

Jan

;

27

(

1-2

):

47

–

51

.

[PubMed]

0334-018X

https://doi.org/10.1210/jc.2007-0321

53.

Lazar

L

,

Padoa

A

,

Phillip

M

.

Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity

.

J Clin Endocrinol Metab

.

2007

Sep

;

92

(

9

):

3483

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2007-1216

54.

Pasquino

AM

,

Pucarelli

I

,

Accardo

F

,

Demiraj

V

,

Segni

M

,

Di Nardo

R

.

Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function

.

J Clin Endocrinol Metab

.

2008

Jan

;

93

(

1

):

190

–

5

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2009-0793

55.

Magiakou

MA

,

Manousaki

D

,

Papadaki

M

,

Hadjidakis

D

,

Levidou

G

,

Vakaki

M

, et al.

The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study

.

J Clin Endocrinol Metab

.

2010

Jan

;

95

(

1

):

109

–

17

.

[PubMed]

0021-972X

https://doi.org/10.1530/EJE-15-0590

56.

Guaraldi

F

,

Beccuti

G

,

Gori

D

,

Ghizzoni

L

.

MANAGEMENT OF ENDOCRINE DISEASE: long-term outcomes of the treatment of central precocious puberty

.

Eur J Endocrinol

.

2016

Mar

;

174

(

3

):

R79

–

87

.

[PubMed]

0804-4643

https://doi.org/10.1159/000441497

57.

Bertelloni

S

,

Massart

F

,

Einaudi

S

,

Wasniewska

M

,

Miccoli

M

,

Baroncelli

GI

.

Central Precocious Puberty: Adult Height in Girls Treated with Quarterly or Monthly Gonadotropin-Releasing Hormone Analog Triptorelin

.

Horm Res Paediatr

.

2015

;

84

(

6

):

396

–

400

.

[PubMed]

1663-2818

58.

Heger

S

,

Partsch

CJ

,

Sippell

WG

.

Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function

.

J Clin Endocrinol Metab

.

1999

Dec

;

84

(

12

):

4583

–

90

.

[PubMed]

0021-972X

https://doi.org/10.1007/s00431-017-2898-8

59.

Bertelloni

S

,

Massart

F

,

Miccoli

M

,

Baroncelli

GI

.

Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis.

Eur J Pediatr.

2017

;176(6):697-704.LoE-2

https://doi.org/10.1159/000491103

60.

Kaplowitz

PB

,

Backeljauw

PF

,

Allen

DB

.

Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty

.

Horm Res Paediatr

.

2018

;

90

(

1

):

1

–

7

.

[PubMed]

1663-2818

https://doi.org/10.1210/jc.2011-2704

61.

Lee

PA

,

Klein

K

,

Mauras

N

,

Neely

EK

,

Bloch

CA

,

Larsen

L

, et al.

Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty

.

J Clin Endocrinol Metab

.

2012

May

;

97

(

5

):

1572

–

80

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2014-3031

62.

Silverman

LA

,

Neely

EK

,

Kletter

GB

,

Lewis

K

,

Chitra

S

,

Terleckyj

O

, et al.

Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial

.

J Clin Endocrinol Metab

.

2015

Jun

;

100

(

6

):

2354

–

63

.

[PubMed]

0021-972X

63.

Glab

E

,

Wikiera

B

,

Bieniasz

J

,

Barg

E.

The Influence of GnRH Analog Therapy on Growth in Central Precocious Puberty.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

2016

;25(1):27-32.

https://doi.org/10.1515/jpem-2017-0523

64.

Klein

KO

,

Dragnic

S

,

Soliman

AM

,

Bacher

P

.

Predictors of bone maturation, growth rate and adult height in children with central precocious puberty treated with depot leuprolide acetate

.

J Pediatr Endocrinol Metab

.

2018

Jun

;

31

(

6

):

655

–

63

.

[PubMed]

0334-018X

https://doi.org/10.1515/jpem-2016-0026

65.

Lee

PA

,

Luce

M

,

Bacher

P

.

Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation

.

J Pediatr Endocrinol Metab

.

2016

Nov

;

29

(

11

):

1249

–

57

.

[PubMed]

0334-018X

https://doi.org/10.1111/j.1365-2265.2011.04185.x

66.

Demirbilek

H

,

Alikasifoglu

A

,

Gonc

NE

,

Ozon

A

,

Kandemir

N

.

Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection

.

Clin Endocrinol (Oxf)

.

2012

Jan

;

76

(

1

):

126

–

30

.

[PubMed]

0300-0664

https://doi.org/10.1210/jc.2003-031537

67.

Brito

VN

,

Latronico

AC

,

Arnhold

IJ

,

Mendonca

BB

.

A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls

.

J Clin Endocrinol Metab

.

2004

Sep

;

89

(

9

):

4338

–

42

.

[PubMed]

0021-972X

https://doi.org/10.14310/horm.2002.1690

68.

Lucaccioni

L

,

McNeilly

J

,

Mason

A

,

Giacomozzi

C

,

Kyriakou

A

,

Shaikh

MG

, et al.

The measurement of urinary gonadotropins for assessment and management of pubertal disorder

.

Hormones (Athens)

.

2016

Jul

;

15

(

3

):

377

–

84

.

[PubMed]

1109-3099

https://doi.org/10.1016/j.jpeds.2012.08.038

69.

Lewis

KA

,

Eugster

EA

.

Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty

.

J Pediatr

.

2013

Mar

;

162

(

3

):

562

–

5

.

[PubMed]

0022-3476

https://doi.org/10.1210/jc.2007-2183

70.

Brito

VN

,

Latronico

AC

,

Cukier

P

,

Teles

MG

,

Silveira

LF

,

Arnhold

IJ

, et al.

Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs

.

J Clin Endocrinol Metab

.

2008

Jul

;

93

(

7

):

2662

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1210/jcem.86.10.7915

71.

Klein

KO

,

Barnes

KM

,

Jones

JV

,

Feuillan

PP

,

Cutler

GB

Jr.

Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience

.

J Clin Endocrinol Metab

.

2001

Oct

;

86

(

10

):

4711

–

6

.

[PubMed]

0021-972X

https://doi.org/10.1136/adc.75.4.292

72.

Oostdijk

W

,

Rikken

B

,

Schreuder

S

,

Otten

B

,

Odink

R

,

Rouwé

C

, et al.

Final height in central precocious puberty after long term treatment with a slow release GnRH agonist

.

Arch Dis Child

.

1996

Oct

;

75

(

4

):

292

–

7

.

[PubMed]

0003-9888

https://doi.org/10.1210/jcem.84.6.5647

73.

Carel

JC

,

Roger

M

,

Ispas

S

,

Tondu

F

,

Lahlou

N

,

Blumberg

J

, et al.

Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty

.

J Clin Endocrinol Metab

.

1999

Jun

;

84

(

6

):

1973

–

8

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2007-0321

74.

Lazar

L

,

Padoa

A

,

Phillip

M

.

Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity

.

J Clin Endocrinol Metab

.

2007

Sep

;

92

(

9

):

3483

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1016/j.clinthera.2010.09.009

75.

Miller

BS

,

Shukla

AR

.

Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists

.

Clin Ther

.

2010

Sep

;

32

(

10

):

1749

–

51

.

[PubMed]

0149-2918

https://doi.org/10.1016/j.jpedsurg.2014.02.067

76.

Davis

JS

,

Alkhoury

F

,

Burnweit

C

.

Surgical and anesthetic considerations in histrelin capsule implantation for the treatment of precocious puberty

.

J Pediatr Surg

.

2014

May

;

49

(

5

):

807

–

10

.

[PubMed]

0022-3468

https://doi.org/10.1186/1687-9856-2009-812517

77.

Rahhal

S

,

Clarke

WL

,

Kletter

GB

,

Lee

PA

,

Neely

EK

,

Reiter

EO

, et al.

Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty

.

Int J Pediatr Endocrinol

.

2009

;

2009

(

1

):

812517

.

[PubMed]

1687-9848

https://doi.org/10.1016/S0887-8994(00)00181-8

78.

Akaboshi

S

,

Takeshita

K

.

A case of atypical absence seizures induced by leuprolide acetate

.

Pediatr Neurol

.

2000

Sep

;

23

(

3

):

266

–

8

.

[PubMed]

0887-8994

https://doi.org/10.1016/j.eururo.2014.11.039

79.

Bosco

C

,

Bosnyak

Z

,

Malmberg

A

,

Adolfsson

J

,

Keating

NL

,

Van Hemelrijck

M

.

Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis

.

Eur Urol

.

2015

Sep

;

68

(

3

):

386

–

96

.

[PubMed]

0302-2838

https://doi.org/10.3322/caac.20061

80.

Levine

GN

,

D’Amico

AV

,

Berger

P

,

Clark

PE

,

Eckel

RH

,

Keating

NL

, et al.;

American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association

.

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

.

CA Cancer J Clin

.

2010

May-Jun

;

60

(

3

):

194

–

201

.

[PubMed]

0007-9235

https://doi.org/10.1161/CIRCULATIONAHA.109.192704

81.

Drew

BJ

,

Ackerman

MJ

,

Funk

M

,

Gibler

WB

,

Kligfield

P

,

Menon

V

, et al.;

American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology Foundation

.

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation

.

Circulation

.

2010

Mar

;

121

(

8

):

1047

–

60

.

[PubMed]

0009-7322

https://doi.org/10.1159/000351028

82.

Inman

M

,

Hursh

BE

,

Mokashi

A

,

Pinto

T

,

Metzger

DL

,

Cummings

EA

.

Occurrence of slipped capital femoral epiphysis in children undergoing gonadotropin-releasing hormone agonist therapy for the treatment of central precocious puberty

.

Horm Res Paediatr

.

2013

;

80

(

1

):

64

–

8

.

[PubMed]

1663-2818

https://doi.org/10.1016/j.jocn.2014.08.015

83.

Sasagawa

Y

,

Tachibana

O

,

Nakagawa

A

,

Koya

D

,

Iizuka

H

.

Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma

.

J Clin Neurosci

.

2015

Mar

;

22

(

3

):

601

–

3

.

[PubMed]

0967-5868

https://doi.org/10.1038/nrendo.2014.40

84.

Willemsen

RH

,

Elleri

D

,

Williams

RM

,

Ong

KK

,

Dunger

DB

.

Pros and cons of GnRHa treatment for early puberty in girls

.

Nat Rev Endocrinol

.

2014

Jun

;

10

(

6

):

352

–

63

.

[PubMed]

1759-5029

https://doi.org/10.1159/000336325

85.

Sørensen

K

,

Mouritsen

A

,

Aksglaede

L

,

Hagen

CP

,

Mogensen

SS

,

Juul

A

.

Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty

.

Horm Res Paediatr

.

2012

;

77

(

3

):

137

–

45

.

[PubMed]

1663-2818

https://doi.org/10.3109/02841869409098400

86.

Stoll

BA

,

Vatten

LJ

,

Kvinnsland

S

.

Does early physical maturity influence breast cancer risk?

Acta Oncol

.

1994

;

33

(

2

):

171

–

6

.

[PubMed]

0284-186X

https://doi.org/10.1038/ijo.2012.177

87.

Prentice

P

,

Viner

RM

.

Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis.

Int J Obes (Lond).

2013

;37(8):1036-1043.LoE-2

https://doi.org/10.1210/jcem.84.1.5409

88.

Feuillan

PP

,

Jones

JV

,

Barnes

K

,

Oerter-Klein

K

,

Cutler

GB

Jr.

Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty

.

J Clin Endocrinol Metab

.

1999

Jan

;

84

(

1

):

44

–

9

.

[PubMed]

0021-972X

https://doi.org/10.1111/cen.12319

89.

Lazar

L

,

Meyerovitch

J

,

de Vries

L

,

Phillip

M

,

Lebenthal

Y

.

Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades

.

Clin Endocrinol (Oxf)

.

2014

Apr

;

80

(

4

):

570

–

6

.

[PubMed]

0300-0664

https://doi.org/10.1007/s004310051289

90.

Bertelloni

S

,

Baroncelli

GI

,

Ferdeghini

M

,

Menchini-Fabris

F

,

Saggese

G

.

Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues

.

Eur J Pediatr

.

2000

May

;

159

(

5

):

369

–

74

.

[PubMed]

0340-6199

https://doi.org/10.1007/s40272-015-0130-8

91.

Chen

M

,

Eugster

EA

.

Central Precocious Puberty: Update on Diagnosis and Treatment

.

Paediatr Drugs

.

2015

Aug

;

17

(

4

):

273

–

81

.

[PubMed]

1174-5878

https://doi.org/10.1210/jc.2013-1024

92.

Fuqua

JS

.

Treatment and outcomes of precocious puberty: an update

.

J Clin Endocrinol Metab

.

2013

Jun

;

98

(

6

):

2198

–

207

.

[PubMed]

0021-972X

https://doi.org/10.1210/jc.2006-2012

93.

Rosenfield

RL

.

Clinical review: identifying children at risk for polycystic ovary syndrome

.

J Clin Endocrinol Metab

.

2007

Mar

;

92

(

3

):

787

–

96

.

[PubMed]

0021-972X

https://doi.org/10.1016/j.fertnstert.2008.11.016

94.

Franceschi

R

,

Gaudino

R

,

Marcolongo

A

,

Gallo

MC

,

Rossi

L

,

Antoniazzi

F

, et al.

Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty

.

Fertil Steril

.

2010

Mar

;

93

(

4

):

1185

–

91

.

[PubMed]

0015-0282

https://doi.org/10.1530/EJE-09-1102

95.

Chiavaroli

V

,

Liberati

M

,

D’Antonio

F

,

Masuccio

F

,

Capanna

R

,

Verrotti

A

, et al.

GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome

.

Eur J Endocrinol

.

2010

Jul

;

163

(

1

):

55

–

62

.

[PubMed]

0804-4643

https://doi.org/10.3345/kjp.2015.58.1.1

96.

Kim

EY

.

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty

.

Korean J Pediatr

.

2015

Jan

;

58

(

1

):

1

–

7

.

[PubMed]

1738-1061

https://doi.org/10.1016/j.mce.2006.04.012

97.

Heger

S

,

Müller

M

,

Ranke

M

,

Schwarz

HP

,

Waldhauser

F

,

Partsch

CJ

, et al.

Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function

.

Mol Cell Endocrinol

.

2006

Jul

;

254-255

:

217

–

20

.

[PubMed]

0303-7207

https://doi.org/10.18632/oncotarget.19180

98.

Ding

T

,

Hardiman

PJ

,

Petersen

I

,

Wang

FF

,

Qu

F

,

Baio

G

.

The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.

Oncotarget.

2017

;8(56):96351-96358.LoE-3

https://doi.org/10.1159/000479371

99.

Ibáñez

L

,

Oberfield

SE

,

Witchel

S

,

Auchus

RJ

,

Chang

RJ

,

Codner

E

, et al.

An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence

.

Horm Res Paediatr

.

2017

;

88

(

6

):

371

–

95

.

[PubMed]

1663-2818

100.

Baumann

DA

,

Landolt

MA

,

Wetterwald

R

,

Dubuis

JM

,

Sizonenko

PC

,

Werder

EA

.

Psychological evaluation of young women after medical treatment for central precocious puberty

.

Horm Res

.

2001

;

56

(

1-2

):

45

–

50

.

[PubMed]

0301-0163

https://doi.org/10.4306/pi.2012.9.1.25

101.

Kim

EY

,

Lee

MI

.

Psychosocial aspects in girls with idiopathic precocious puberty

.

Psychiatry Investig

.

2012

Mar

;

9

(

1

):

25

–

8

.

[PubMed]

1738-3684

https://doi.org/10.1111/j.1651-2227.1997.tb08602.x

102.

Xhrouet-Heinrichs

D

,

Lagrou

K

,

Heinrichs

C

,

Craen

M

,

Dooms

L

,

Malvaux

P

, et al.

Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy

.

Acta Paediatr

.

1997

Aug

;

86

(

8

):

808

–

15

.

[PubMed]

0803-5253

https://doi.org/10.1186/s13633-015-0001-7

103.

Schoelwer

MJ

,

Donahue

KL

,

Bryk

K

,

Didrick

P

,

Berenbaum

SA

,

Eugster

EA

.

Psychological assessment of mothers and their daughters at the time of diagnosis of precocious puberty

.

Int J Pediatr Endocrinol

.

2015

;

2015

(

1

):

5

.

[PubMed]

1687-9848

https://doi.org/10.1515/jpem-2016-0425

104.

Menk

TA

,

Inácio

M

,

Macedo

DB

,

Bessa

DS

,

Latronico

AC

,

Mendonca

BB

, et al.

Assessment of stress levels in girls with central precocious puberty before and during long-acting gonadotropin-releasing hormone agonist treatment: a pilot study

.

J Pediatr Endocrinol Metab

.

2017

May

;

30

(

6

):

657

–

62

.

[PubMed]

0334-018X

https://doi.org/10.1210/jcem.87.2.8202

105.

van der Sluis

IM

,

Boot

AM

,

Krenning

EP

,

Drop

SL

,

de Muinck Keizer-Schrama

SM

.

Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy

.

J Clin Endocrinol Metab

.

2002

Feb

;

87

(

2

):

506

–

12

.

[PubMed]

0021-972X

https://doi.org/10.1111/j.1365-2265.2004.02146.x

106.

Paterson

WF

,

McNeill

E

,

Young

D

,

Donaldson

MD

.

Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty

.

Clin Endocrinol (Oxf)

.

2004

Nov

;

61

(

5

):

626

–

34

.

[PubMed]

0300-0664

https://doi.org/10.1530/eje.1.01975

107.

Traggiai

C

,

Perucchin

PP

,

Zerbini

K

,

Gastaldi

R

,

De Biasio

P

,

Lorini

R

.

Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height

.

Eur J Endocrinol

.

2005

Sep

;

153

(

3

):

463

–

4

.

[PubMed]

0804-4643

https://doi.org/10.1159/000346145

108.

Wolters

B

,

Lass

N

,

Reinehr

T

.

Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children

.

Horm Res Paediatr

.

2012

;

78

(

5-6

):

304

–

11

.

[PubMed]

1663-2818

https://doi.org/10.1530/eje.0.1500533

109.

Arrigo

T

,

De Luca

F

,

Antoniazzi

F

,

Galluzzi

F

,

Segni

M

,

Rosano

M

, et al.

Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty

.

Eur J Endocrinol

.

2004

Apr

;

150

(

4

):

533

–

7

.

[PubMed]

0804-4643

110.

Palmert

MR

,

Mansfield

MJ

,

Crowley

WF

Jr,

Crigler

JF

Jr,

Crawford

JD

,

Boepple

PA

.

Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty

.

J Clin Endocrinol Metab

.

1999

Dec

;

84

(

12

):

4480

–

8

.

[PubMed]

0021-972X

111.

Boot

AM

,

De Muinck Keizer-Schrama

S

,

Pols

HA

,

Krenning

EP

,

Drop

SL

.

Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty

.

J Clin Endocrinol Metab

.

1998

Feb

;

83

(

2

):

370

–

3

.

[PubMed]

0021-972X

https://doi.org/10.1515/JPEM.2006.19.11.1327

112.

Aguiar

AL

,

Couto-Silva

AC

,

Vicente

EJ

,

Freitas

IC

,

Cruz

T

,

Adan

L

.

Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues

.

J Pediatr Endocrinol Metab

.

2006

Nov

;

19

(

11

):

1327

–

34

.

[PubMed]

0334-018X

https://doi.org/10.1530/eje.0.151s047

113.

Lazar

L

,

Lebenthal

Y

,

Yackobovitch-Gavan

M

,

Shalitin

S

,

de Vries

L

,

Phillip

M

,

Meyerovitch

J

. Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades. J Clin Endocrinol Metab.

2015

;100(4):1445-1451.LoE-3

114.

Antoniazzi

F

,

Zamboni

G

,

Bertoldo

F

,

Lauriola

S

,

Tatò

L

.

Bone development during GH and GnRH analog treatment

.

Eur J Endocrinol

.

2004

Aug

;

151

Suppl 1

:

S47

–

54

.

[PubMed]

0804-4643

https://doi.org/10.1159/000456546

115.

Yanovski

JA

,

Rose

SR

,

Municchi

G

,

Pescovitz

OH

,

Hill

SC

,

Cassorla

FG

,

Cutler

GB

, Jr. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med.

2003

;348(10):908-917.LoE-1

116.

Faienza

MF

,

Brunetti

G

,

Acquafredda

A

,

Delvecchio

M

,

Lonero

A

,

Gaeta

A

, et al.

Metabolic Outcomes, Bone Health, and Risk of Polycystic Ovary Syndrome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues

.

Horm Res Paediatr

.

2017

;

87

(

3

):

162

–

9

.

[PubMed]

1663-2818

https://doi.org/10.1210/jc.2017-01658

117.

Hembree

WC

,

Cohen-Kettenis

PT

,

Gooren

L

,

Hannema

SE

,

Meyer

WJ

,

Murad

MH

, et al.

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline

.

J Clin Endocrinol Metab

.

2017

Nov

;

102

(

11

):

3869

–

903

.

[PubMed]

0021-972X

https://doi.org/10.1080/15532739.2011.700873

118.

Coleman

E

,

Bockting

W

,

Botzer

M

,

Cohen-Kettenis

P

,

DeCuypere

G

,

Feldman

J

, et al.

K.R. W, K. Z. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7

.

Int J Transgenderism

.

2012

;

13

(

4

):

165

–

232

.

1553-2739

https://doi.org/10.1038/nrendo.2011.78

119.

Kreukels

BP

,

Cohen-Kettenis

PT

.

Puberty suppression in gender identity disorder: the Amsterdam experience

.

Nat Rev Endocrinol

.

2011

May

;

7

(

8

):

466

–

72

.

[PubMed]

1759-5029

https://doi.org/10.1080/00918369.2012.653300

120.

de Vries

AL

,

Cohen-Kettenis

PT

.

Clinical management of gender dysphoria in children and adolescents: the Dutch approach

.

J Homosex

.

2012

;

59

(

3

):

301

–

20

.

[PubMed]

0091-8369

https://doi.org/10.1016/j.jsxm.2016.05.004

121.

Schagen

SE

,

Cohen-Kettenis

PT

,

Delemarre-van de Waal

HA

,

Hannema

SE

.

Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents

.

J Sex Med

.

2016

Jul

;

13

(

7

):

1125

–

32

.

[PubMed]

1743-6095

https://doi.org/10.1542/peds.2017-3742

122.

Chew

D

,

Anderson

J

,

Williams

K

,

May

T

,

Pang

K

.

Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review

.

Pediatrics

.

2018

Apr

;

141

(

4

):

e20173742

.

[PubMed]

0031-4005

https://doi.org/10.1210/jc.2014-2439

123.

Klink

D

,

Caris

M

,

Heijboer

A

,

van Trotsenburg

M

,

Rotteveel

J

.

Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria

.

J Clin Endocrinol Metab

.

2015

Feb

;

100

(

2

):

E270

–

5

.

[PubMed]

0021-972X

https://doi.org/10.2147/AHMT.S110859

124.

Ehrensaft

D

.

Gender nonconforming youth: current perspectives

.

Adolesc Health Med Ther

.

2017

May

;

8

:

57

–

67

.

[PubMed]

1179-318X

https://doi.org/10.1159/000182690

125.

Thomas

BC

,

Stanhope

R

,

Leiper

AD

.

Gonadotropin releasing hormone analogue and growth hormone therapy in precocious and premature puberty following cranial irradiation for acute lymphoblastic leukaemia

.

Horm Res

.

1993

;

39

(

1-2

):

25

–

9

.

[PubMed]

0301-0163

https://doi.org/10.1016/S0022-3476(05)80232-X

126.

Cara

JF

,

Kreiter

ML

,

Rosenfield

RL

.

Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone

.

J Pediatr

.

1992

May

;

120

(

5

):

709

–

15

.

[PubMed]

0022-3476

https://doi.org/10.1210/jc.82.1.229

127.

Adan

L

,

Souberbielle

JC

,

Zucker

JM

,

Pierre-Kahn

A

,

Kalifa

C

,

Brauner

R

.

Adult height in 24 patients treated for growth hormone deficiency and early puberty

.

J Clin Endocrinol Metab

.

1997

Jan

;

82

(

1

):

229

–

33

.

[PubMed]

0021-972X

128.

Kohn

B

,

Julius

JR

,

Blethen

SL

.

Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience

.

Pediatrics

.

1999

Oct

;

104

(

4 Pt 2

):

1014

–

8

.

[PubMed]

0031-4005

https://doi.org/10.1210/jc.2007-1559

129.

Mauras

N

,

Attie

KM

,

Reiter

EO

,

Saenger

P

,

Baptista

J

. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group [In Process Citation]. J Clin Endocrinol Metab.

2000

;85(10):3653-3660.LoE-2

130.

Mauras

N

,

Gonzalez de Pijem

L

,

Hsiang

HY

,

Desrosiers

P

,

Rapaport

R

,

Schwartz

ID

, et al.

Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years

.

J Clin Endocrinol Metab

.

2008

Mar

;

93

(

3

):

823

–

31

.

[PubMed]

0021-972X

131.

Mericq

MV

,

Eggers

M

,

Avila

A

,

Cutler

GB

Jr,

Cassorla

F

.

Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial

.

J Clin Endocrinol Metab

.

2000

Feb

;

85

(

2

):

569

–

73

.

[PubMed]

0021-972X

https://doi.org/10.1210/jcem.86.10.7910

132.

Mul

D

,

Wit

JM

,

Oostdijk

W

,

Van den Broeck

J

;

Dutch Advisory Group on Growth Hormone

.

The effect of pubertal delay by GnRH agonist in GH-deficient children on final height

.

J Clin Endocrinol Metab

.

2001

Oct

;

86

(

10

):

4655

–

6

.

[PubMed]

0021-972X

https://doi.org/10.1210/jcem.84.10.6032

133.

Bouvattier

C

,

Coste

J

,

Rodrigue

D

,

Teinturier

C

,

Carel

JC

,

Chaussain

JL

, et al.

Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study

.

J Clin Endocrinol Metab

.

1999

Oct

;

84

(

10

):

3575

–

8

.

[PubMed]

0021-972X

134.

Cassio

A

,

Cacciari

E

,

Balsamo

A

,

Bal

M

,

Tassinari

D.

Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child.

1999

;81(4):329-332.LoE-1

135.

Carel

JC

,

Hay

F

,

Coutant

R

,

Rodrigue

D

,

Chaussain

JL

.

Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development

.

J Clin Endocrinol Metab

.

1996

Sep

;

81

(

9

):

3318

–

22

.

[PubMed]

0021-972X

https://doi.org/10.1210/jcem.87.5.8481

136.

Lazar

L

,

Kauli

R

,

Pertzelan

A

,

Phillip

M

.

Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height

.

J Clin Endocrinol Metab

.

2002

May

;

87

(

5

):

2090

–

4

.

[PubMed]

0021-972X

137.

Khawaja

N

,

Owaineh

H

,

Batieha

A

,

Frahid

O

,

El-Khateeb

M

,

Ajlouni

KM

.

The Effect of Gonadotropin-Releasing Hormone Analogue on Final Adult Height in Children with Idiopathic Short Stature

.

Med Princ Pract

.

2019

Apr

.

[PubMed]

1423-0151

https://doi.org/10.1046/j.1365-2265.1998.00499.x

138.

Lanes

R

,

Gunczler

P

.

Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty

.

Clin Endocrinol (Oxf)

.

1998

Aug

;

49

(

2

):

197

–

202

.

[PubMed]

0300-0664

https://doi.org/10.1159/000183889

139.

Job

JC

,

Toublanc

JE

,

Landier

F

.

Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist

.

Horm Res

.

1994

;

41

(

5-6

):

177

–

84

.

[PubMed]

0301-0163

https://doi.org/10.1111/j.1365-2265.2005.02323.x

140.

Mul

D

,

Oostdijk

W

,

Waelkens

JJ

,

Drop

SL

.

Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone

.

Clin Endocrinol (Oxf)

.

2005

Aug

;

63

(

2

):

185

–

90

.

[PubMed]

0300-0664

https://doi.org/10.1111/j.1651-2227.2004.tb02629.x

141.

Tuvemo

T

,

Jonsson

B

,

Gustafsson

J

,

Albertsson-Wikland

K

,

Aronson

AS

,

Häger

A

, et al.

Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty

.

Acta Paediatr

.

2004

Nov

;

93

(

11

):

1456

–

62

.

[PubMed]

0803-5253

https://doi.org/10.1210/jcem.85.2.6387

142.

Pasquino

AM

,

Pucarelli

I

,

Roggini

M

,

Segni

M

.

Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone

.

J Clin Endocrinol Metab

.

2000

Feb

;

85

(

2

):

619

–

22

.

[PubMed]

0021-972X

https://doi.org/10.1530/EC-18-0137

143.

Benabbad

I

,

Rosilio

M

,

Tauber

M

,

Paris

E

,

Paulsen

A

,

Berggren

L

, et al.;

Phoenix Study Group

.

Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature

.

Endocr Connect

.

2018

May

;

7

(

5

):

708

–

18

.

[PubMed]

2049-3614

https://doi.org/10.1515/jpem-2012-0345

144.

Hernández

MI

,

Martínez-Aguayo

A

,

Cavada

G

,

Peña

V

,

Trejo

L

,

Avila

A

, et al.

Accelerated early pubertal progression, ovarian morphology, and ovarian function in prospectively followed low birth weight (LBW) girls

.

J Pediatr Endocrinol Metab

.

2013

;

26

(

3-4

):

223

–

30

.

[PubMed]

0334-018X

https://doi.org/10.1530/eje.0.1490425

145.

Lazar

L

,

Pollak

U

,

Kalter-Leibovici

O

,

Pertzelan

A

,

Phillip

M

.

Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)

.

Eur J Endocrinol

.

2003

Nov

;

149

(

5

):

425

–

32

.

[PubMed]

0804-4643

https://doi.org/10.1210/jc.2016-1317

146.

Lem

AJ

,

van der Kaay

DC

,

de Ridder

MA

,

Bakker-van Waarde

WM

,

van der Hulst

FJ

,

Mulder

JC

,

Noordam

C

,

Odink

RJ

,

Oostdijk

W

,

Schroor

EJ

,

Sulkers

EJ

,

Westerlaken

C

,

Hokken-Koelega

AC

. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J Clin Endocrinol Metab.

2012

;97(11):4096-4105.LoE-2

147.

van der Steen

M

,

Lem

AJ

,

van der Kaay

DC

,

Hokken-Koèelega

AC

.

Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa

.

J Clin Endocrinol Metab

.

2016

May

;

101

(

5

):

2005

–

12

.

[PubMed]

0021-972X

https://doi.org/10.1095/biolreprod52.2.365

148.

Ataya

K

,

Rao

LV

,

Lawrence

E

,

Kimmel

R

.

Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys

.

Biol Reprod

.

1995

Feb

;

52

(

2

):

365

–

72

.

[PubMed]

0006-3363

https://doi.org/10.1001/jamaoncol.2015.3251

149.

Hickman

LC

,

Llarena

NC

,

Valentine

LN

,

Liu

X

,

Falcone

T

. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists. J Assist Reprod Genet.

2018

;35(4):571-581.LoE-2

150.

Munhoz

RR

,

Pereira

AA

,

Sasse

AD

,

Hoff

PM

,

Traina

TA

,

Hudis

CA

, et al.

Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis

.

JAMA Oncol

.

2016

Jan

;

2

(

1

):

65

–

73

.

[PubMed]

2374-2437

https://doi.org/10.1016/j.ctrv.2013.12.001

151.

Del Mastro

L

,

Ceppi

M

,

Poggio

F

,

Bighin

C

,

Peccatori

F

,

Demeestere

I

,

Levaggi

A

,

Giraudi

S

,

Lambertini

M

,

D'Alonzo

A

,

Canavese

G

,

Pronzato

P

,

Bruzzi

P

.

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.

Cancer Treat Rev.

2014

;40(5):675-683.LoE-2

https://doi.org/10.1371/journal.pone.0080444

152.

Zhang

Y

,

Xiao

Z

,

Wang

Y

,

Luo

S

,

Li

X

,

Li

S

.

Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients

.

PLoS One

.

2013

Nov

;

8

(

11

):

e80444

.

[PubMed]

1932-6203

https://doi.org/10.2217/WHE.11.72

153.

Blumenfeld

Z

.

Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs

.

Womens Health (Lond)

.

2011

Nov

;

7

(

6

):

635

–

40

.

[PubMed]

1745-5065

https://doi.org/10.1016/j.fertnstert.2012.07.1144

154.

Blumenfeld

Z

,

Patel

B

,

Leiba

R

,

Zuckerman

T

.

Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation

.

Fertil Steril

.

2012

Nov

;

98

(

5

):

1266

–

70.e1

.

[PubMed]

0015-0282

https://doi.org/10.1007/s00404-009-1308-5

155.

Nitzschke

M

,

Raddatz

J

,

Bohlmann

MK

,

Stute

P

,

Strowitzki

T

,

von Wolff

M

.

GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin’s lymphoma patients

.

Arch Gynecol Obstet

.

2010

Jul

;

282

(

1

):

83

–

8

.

[PubMed]

0932-0067

https://doi.org/10.1007/s10815-008-9276-4

156.

Azem

F

,

Samara

N

,

Cohen

T

,

Ben-Yosef

D

,

Almog

B

,

Lessing

JB

, et al.

Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin’s disease

.

J Assist Reprod Genet

.

2008

Nov-Dec

;

25

(

11-12

):

535

–

8

.

[PubMed]

1058-0468

https://doi.org/10.1001/jamaoncol.2015.3252

157.

Demeestere

I

,

Brice

P

,

Peccatori

FA

,

Kentos

A

,

Dupuis

J

,

Zachee

P

,

Casasnovas

O

,

Van Den Neste

E

,

Dechene

J

,

De Maertelaer

V

,

Bron

D

,

Englert

Y

. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial. J Clin Oncol.

2016

;34(22):2568-2574.LoE-1

158.

Oktay

K

,

Turan

V

.

Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence

.

JAMA Oncol

.

2016

Jan

;

2

(

1

):

74

–

5

.

[PubMed]

2374-2437

https://doi.org/10.5468/ogs.2018.61.4.443

159.

Moore

HC

,

Unger

JM

,

Phillips

KA

,

Boyle

F

,

Hitre

E

,

Porter

D

,

Francis

PA

,

Goldstein

LJ

,

Gomez

HL

,

Vallejos

CS

,

Partridge

AH

,

Dakhil

SR

,

Garcia

AA

,

Gralow

J

,

Lombard

JM

,

Forbes

JF

,

Martino

S

,

Barlow

WE

,

Fabian

CJ

,

Minasian

L

,

Meyskens

FL

,

Gelber

RD

,

Hortobagyi

GN

,

Albain

KS

,

Investigators

PS

. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med.

2015

;372(10):923-932.LoE-1

160.

Sugishita

Y

,

Suzuki

N

.

Fertility preservation for adolescent and young adult cancer patients in Japan

.

Obstet Gynecol Sci

.

2018

Jul

;

61

(

4

):

443

–

52

.

[PubMed]

2287-8572

https://doi.org/10.2174/09298673113206660293

161.

Chahvar

ST

,

Al-Shawaf

T

,

Tranquilli

AL

.

Pharmacologic ovarian preservation in young women undergoing chemotherapy

.

Curr Med Chem

.

2014

;

21

(

2

):

223

–

9

.

[PubMed]

0929-8673

162.

Geier

DA

,

Geier

MR

.

A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders

.

Neuro Endocrinol Lett

.

2006

Dec

;

27

(

6

):

833

–

8

.

[PubMed]

0172-780X

https://doi.org/10.1542/peds.2015-4366

163.

Coshway

L

,

Broussard

J

,

Acharya

K

,

Fried

K

,

Msall

ME

,

Lantos

JD

, et al.

Medical Therapy for Inappropriate Sexual Behaviors in a Teen With Autism Spectrum Disorder

.

Pediatrics

.

2016

Apr

;

137

(

4

):

e20154366

.

[PubMed]

0031-4005